These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28870861)

  • 1. Sleep Problems are Associated with Development and Progression of Lower Urinary Tract Symptoms: Results from REDUCE.
    Branche BL; Howard LE; Moreira DM; Roehrborn C; Castro-Santamaria R; Andriole GL; Hopp ML; Freedland SJ
    J Urol; 2018 Feb; 199(2):536-542. PubMed ID: 28870861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin Use and Lower Urinary Tract Symptoms Incidence and Progression in Reduction by Dutasteride of Prostate Cancer Events (REDUCE) Trial.
    Kramer JJ; Gu L; Moreira D; Andriole G; Csizmadi I; Freedland SJ
    J Urol; 2022 Feb; 207(2):417-423. PubMed ID: 34544265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Peak Urine Flow Rate Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from REDUCE.
    Simon RM; Howard LE; Moreira DM; Roehrborn C; Vidal A; Castro-Santamaria R; Freedland SJ
    J Urol; 2017 Sep; 198(3):650-656. PubMed ID: 28428110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention.
    Nickel JC; Roehrborn CG; Castro-Santamaria R; Freedland SJ; Moreira DM
    J Urol; 2016 Nov; 196(5):1493-1498. PubMed ID: 27378134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dutasteride Improves Nocturia but Does Not Lead to Better Sleep: Results from the REDUCE Clinical Trial.
    Kuhlmann PK; Fischer SC; Howard LE; Moreira DM; Andriole GL; Hopp ML; Roehrborn CG; Bliwise DL; Freedland SJ
    J Urol; 2021 Jun; 205(6):1733-1739. PubMed ID: 33605791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cholesterol and risk of lower urinary tract symptoms progression: Results from the Reduction by Dutasteride of Prostate Cancer Events study.
    Feng T; Howard LE; Vidal AC; Moreira DM; Castro-Santamaria R; Andriole GL; Freedland SJ
    Int J Urol; 2017 Feb; 24(2):151-156. PubMed ID: 28004415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking and lower urinary tract symptoms in Reduction by Dutasteride of Prostate Cancer Events Trial.
    Kramer JJ; Gu L; Moreira D; Andriole G; Freedland SJ; Csizmadi I
    Prostate; 2023 Jul; 83(10):990-997. PubMed ID: 37070723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial.
    Simon RM; Howard LE; Moreira DM; Roehrborn C; Vidal AC; Castro-Santamaria R; Freedland SJ
    Eur Urol; 2016 May; 69(5):885-91. PubMed ID: 26724841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSA predicts development of incident lower urinary tract symptoms: results from the REDUCE study.
    Patel DN; Feng T; Simon RM; Howard LE; Vidal AC; Moreira DM; Castro-Santamaria R; Roehrborn C; Andriole GL; Freedland SJ
    Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):238-244. PubMed ID: 29795141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Testosterone and Dihydrotestosterone and Incidence and Progression of Lower Urinary Tract Symptoms: Results From the REDUCE Study.
    Daniels JP; Mirocha J; Adjei M; Moreira D; Freedland SJ
    J Urol; 2024 Jan; 211(1):101-110. PubMed ID: 37873943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship between Sleep Disorders and Lower Urinary Tract Symptoms: Results from the NHANES.
    Fantus RJ; Packiam VT; Wang CH; Erickson BA; Helfand BT
    J Urol; 2018 Jul; 200(1):161-166. PubMed ID: 29408214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for progression or improvement of lower urinary tract symptoms in a prospective cohort of men.
    Martin S; Lange K; Haren MT; Taylor AW; Wittert G;
    J Urol; 2014 Jan; 191(1):130-7. PubMed ID: 23770136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and progression of lower urinary tract symptoms in a large prospective cohort of United States men.
    Platz EA; Joshu CE; Mondul AM; Peskoe SB; Willett WC; Giovannucci E
    J Urol; 2012 Aug; 188(2):496-501. PubMed ID: 22704110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, randomized, double-blind, placebo controlled study of onabotulinumtoxinA 200 U to treat lower urinary tract symptoms in men with benign prostatic hyperplasia.
    McVary KT; Roehrborn CG; Chartier-Kastler E; Efros M; Bugarin D; Chen R; Patel A; Haag-Molkenteller C
    J Urol; 2014 Jul; 192(1):150-6. PubMed ID: 24508634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score.
    Fujimura T; Kume H; Nishimatsu H; Sugihara T; Nomiya A; Tsurumaki Y; Miyazaki H; Suzuki M; Fukuhara H; Enomoto Y; Homma Y
    BJU Int; 2012 May; 109(10):1512-6. PubMed ID: 21883834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of obesity, and the incidence and progression of lower urinary tract symptoms.
    Mondul AM; Giovannucci E; Platz EA
    J Urol; 2014 Mar; 191(3):715-21. PubMed ID: 24076306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep Disturbance Worsens Lower Urinary Tract Symptoms: The Nagahama Study.
    Fukunaga A; Kawaguchi T; Funada S; Yoshino T; Tabara Y; Matsuda F; Yoshimura K; Ogawa O; Negoro H;
    J Urol; 2019 Aug; 202(2):354. PubMed ID: 30865558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: secondary analysis of the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.
    Roehrborn CG; Nickel JC; Andriole GL; Gagnier RP; Black L; Wilson TH; Rittmaster RS
    Urology; 2011 Sep; 78(3):641-6. PubMed ID: 21764428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct effects of tadalafil on lower urinary tract symptoms versus indirect effects mediated through erectile dysfunction symptom improvement: integrated data analyses from 4 placebo controlled clinical studies.
    Brock GB; McVary KT; Roehrborn CG; Watts S; Ni X; Viktrup L; Wong DG; Donatucci C
    J Urol; 2014 Feb; 191(2):405-11. PubMed ID: 24096120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early effect of dutasteride added to alpha-1 blocker therapy for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Araki K; Naya Y; Inahara M; Suzuki F; Ota S; Tsuji H; Mikami K; Yanagisawa M; Awa Y; Suzuki H
    Int J Urol; 2014 Aug; 21(8):815-9. PubMed ID: 24735081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.